Cleared Traditional

S dispensing line (K192770) - FDA 510(k) Clearance

Class II General Hospital device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K192770 · Aea Srl · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2020
Decision
444d
Days
Class 2
Risk

K192770 is an FDA 510(k) clearance for the S dispensing line. Classified as Syringe, Piston (product code FMF), Class II - Special Controls.

Submitted by Aea Srl (Angeli De Rosora, IT). The FDA issued a Cleared decision on December 17, 2020 after a review of 444 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5860 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General Hospital submissions.

View all Aea Srl devices

Submission Details

510(k) Number K192770 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 30, 2019
Decision Date December 17, 2020
Days to Decision 444 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
315d slower than avg
Panel avg: 129d · This submission: 444d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FMF Syringe, Piston
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5860
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMF Syringe, Piston

All 241
Devices cleared under the same product code (FMF) and FDA review panel - the closest regulatory comparables to K192770.
Nanum Syringe
K201930 · Nanum Company Co., Ltd. · Jan 2021
Instylla Delivery Kit
K202544 · Instylla, Inc. · Jan 2021
Insulin Syringe
K193273 · Promisemed Hangzhou Meditech Co., Ltd. · Jan 2021
Sterile Hypodermic Syringe for Single Use, with/without needle, luer/luer-lock, Sterile Insulin Syringe for Single Use, with needle, Sterile Hypodermic needle for Single use
K201284 · Set Medikal Sanayi VE Ticaret Anonim Sirketi · Dec 2020
ARTHROTAP
K201816 · Accuro Technologies, Inc. · Oct 2020
3D GraftRasp System
K201900 · Surgentec · Sep 2020